Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
AMN Healthcare
AMN
$1.34B
| $8.24M | 0.01% |
+167,266
| New | +$7.62M |
|
|
SKX
1802
CALL
DELISTED
Skechers
SKX
| $8.24M | 0.01% |
217,700
-217,900
| -50% | -$7.06M |
|
|
VIAB
1803
CALL
DELISTED
Viacom Inc. Class B
VIAB
| $8.22M | 0.01% |
266,900
+69,500
| +35% | +$1.89M |
|
1804
Neogen
NEOG
$2.54B
| $8.2M | 0.01% |
266,083
-116,725
| -30% | -$3.54M |
|
|
ADSW
1805
DELISTED
Advanced Disposal Services Inc
ADSW
| $8.2M | 0.01% |
342,499
+187,331
| +121% | +$4.43M |
|
1806
PUT
Lear
LEA
$8.32B
| $8.2M | 0.01% |
46,400
+8,900
| +24% | +$1.56M |
|
1807
PUT
Tractor Supply
TSCO
$18.7B
| $8.19M | 0.01% |
548,000
+135,500
| +33% | +$1.74M |
|
|
AMED
1808
DELISTED
Amedisys
AMED
| $8.19M | 0.01% |
155,283
+69,206
| +80% | +$3.65M |
|
1809
Popular Inc
BPOP
$11.3B
| $8.18M | 0.01% |
+230,425
| New | +$7.96M |
|
1810
Evertec
EVTC
$1.89B
| $8.17M | 0.01% |
598,793
+579,899
| +3,069% | +$8.21M |
|
1811
Wendy's
WEN
$1.65B
| $8.16M | 0.01% |
496,762
-440
| -0.1% | -$6.68K |
|
|
CS
1812
CALL
DELISTED
Credit Suisse Group
CS
| $8.16M | 0.01% |
457,000
+63,900
| +16% | +$1.06M |
|
1813
Cooper Companies
COO
$14.9B
| $8.14M | 0.01% |
149,520
-375,168
| -72% | -$21.9M |
|
|
HBI
1814
PUT
DELISTED
Hanesbrands
HBI
| $8.14M | 0.01% |
389,200
+279,800
| +256% | +$5.97M |
|
1815
Simpson Manufacturing
SSD
$7.94B
| $8.12M | ﹤0.01% |
141,381
-39,376
| -22% | -$2.18M |
|
|
CMA
1816
CALL
DELISTED
Comerica
CMA
| $8.1M | ﹤0.01% |
93,300
+19,100
| +26% | +$1.54M |
|
1817
CALL
Crown Castle
CCI
$32.3B
| $8.09M | ﹤0.01% |
72,900
+25,100
| +53% | +$2.71M |
|
1818
PUT
Huntsman Corp
HUN
$1.81B
| $8.09M | ﹤0.01% |
242,900
+150,900
| +164% | +$4.62M |
|
|
CBI
1819
PUT
DELISTED
Chicago Bridge & Iron Nv
CBI
| $8.08M | ﹤0.01% |
500,700
+312,900
| +167% | +$5.1M |
|
|
SKX
1820
PUT
DELISTED
Skechers
SKX
| $8.08M | ﹤0.01% |
213,500
+49,400
| +30% | +$1.6M |
|
1821
Bausch Health
BHC
$2.43B
| $8.07M | ﹤0.01% |
388,496
-1,243,228
| -76% | -$19.7M |
|
1822
CALL
NOV
NOV
$7.54B
| $8.07M | ﹤0.01% |
224,100
-13,500
| -6% | -$457K |
|
1823
PUT
Burlington
BURL
$21.9B
| $8.07M | ﹤0.01% |
65,600
+4,000
| +6% | +$407K |
|
1824
Novartis
NVS
$287B
| $8.07M | ﹤0.01% |
+107,270
| New | +$8.09M |
|
|
WUBA
1825
PUT
DELISTED
58.com Inc
WUBA
| $8.07M | ﹤0.01% |
112,700
+21,900
| +24% | +$1.52M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.